Alkermes plc Announces Intent to Separate Oncology Business
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced approval by its Board of Directors (the Board) to explore separating its commercial-stage...
Source: prnewswire.co.uk
Fast, Ad-Free News Updates
Stay updated with breaking news from Separation Expected. Real-time updates on events, politics, business and more.